SELLAS Life Sciences Group Inc (NASDAQ:SLS) price on Friday, March 21, fall -0.83% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.20.
A look at the stock’s price movement, the close in the last trading session was $1.21, moving within a range at $1.13 and $1.21. The beta value (5-Year monthly) was 2.435. Turning to its 52-week performance, $1.84 and $0.77 were the 52-week high and 52-week low respectively. Overall, SLS moved -8.40% over the past month.
SELLAS Life Sciences Group Inc’s market cap currently stands at around $94.29 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-19.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SLS is a Hold. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend SLS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SLS’s current price about 2.70% and 0.03% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 51.10, while 7-day volatility ratio is 6.41% and 6.24% in the 30-day chart. Further, SELLAS Life Sciences Group Inc (SLS) has a beta value of 2.50, and an average true range (ATR) of 0.09. Analysts have given the company’s stock an average 52-week price target of $2.8, forecast between a low of $2.4 and high of $3.2. Looking at the price targets, the low is -100.0% off current price level while to achieve the yearly target high, price needs to move -166.67%. Nonetheless, investors will most likely welcome a -133.33% jump to $2.8 which is the analysts’ median price.
If we refocus on SELLAS Life Sciences Group Inc (NASDAQ:SLS), historical trading data shows that trading volumes averaged 0.75 over the past 10 days and 2.62 million over the past 3 months. The company’s latest data on shares outstanding shows there are 78.58 million shares.
The 2.08% of SELLAS Life Sciences Group Inc’s shares are in the hands of company insiders while institutional holders own 7.90% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.81 million on 2025-02-28, giving us a short ratio of 2.9. The data shows that as of 2025-02-28 short interest in SELLAS Life Sciences Group Inc (SLS) stood at 995.0000000000001 of shares outstanding, with shares short falling to 9.81 million registered in 2025-01-31. Current price change has pushed the stock 15.38% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SLS stock continues to rise going into the next quarter.
